vs
CATO CORP（CATO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是CATO CORP的1.3倍（$207.3M vs $155.4M），CATO CORP净利率更高（-3.3% vs -62.0%，领先58.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 6.3%），CATO CORP自由现金流更多（$-12.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -5.7%）
凯拓集团（Cato Corporation）是美国女性时装及配饰零售商，总部位于北卡罗来纳州夏洛特市。截至2016年1月，该公司旗下共运营1372家门店，覆盖Cato、Cato Plus、It's Fashion、It's Fashion Metro与Versona多个品牌。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CATO vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $155.4M | $207.3M |
| 净利润 | $-5.2M | $-128.6M |
| 毛利率 | 32.7% | — |
| 营业利润率 | -5.3% | -54.7% |
| 净利率 | -3.3% | -62.0% |
| 营收同比 | 6.3% | 25.9% |
| 净利润同比 | 65.6% | 3.5% |
| 每股收益（稀释后） | $-0.28 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $155.4M | $207.3M | ||
| Q3 25 | $176.5M | $159.9M | ||
| Q2 25 | $170.2M | $166.5M | ||
| Q1 25 | $157.9M | $139.3M | ||
| Q4 24 | $146.2M | $164.6M | ||
| Q3 24 | $168.6M | $139.5M | ||
| Q2 24 | $177.1M | $147.0M | ||
| Q1 24 | $174.9M | $108.8M |
| Q4 25 | $-5.2M | $-128.6M | ||
| Q3 25 | $6.8M | $-180.4M | ||
| Q2 25 | $3.3M | $-115.0M | ||
| Q1 25 | $-14.1M | $-151.1M | ||
| Q4 24 | $-15.1M | $-133.2M | ||
| Q3 24 | $95.0K | $-133.5M | ||
| Q2 24 | $11.0M | $-131.6M | ||
| Q1 24 | — | $-170.7M |
| Q4 25 | 32.7% | — | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 29.2% | — | ||
| Q4 24 | 29.6% | — | ||
| Q3 24 | 35.3% | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 32.1% | — |
| Q4 25 | -5.3% | -54.7% | ||
| Q3 25 | 3.1% | -106.9% | ||
| Q2 25 | 2.0% | -64.8% | ||
| Q1 25 | -15.2% | -102.6% | ||
| Q4 24 | -11.6% | -74.3% | ||
| Q3 24 | -0.4% | -94.6% | ||
| Q2 24 | 3.5% | -79.1% | ||
| Q1 24 | -9.5% | -151.9% |
| Q4 25 | -3.3% | -62.0% | ||
| Q3 25 | 3.9% | -112.8% | ||
| Q2 25 | 1.9% | -69.0% | ||
| Q1 25 | -8.9% | -108.5% | ||
| Q4 24 | -10.3% | -80.9% | ||
| Q3 24 | 0.1% | -95.7% | ||
| Q2 24 | 6.2% | -89.5% | ||
| Q1 24 | — | -156.8% |
| Q4 25 | $-0.28 | $-1.28 | ||
| Q3 25 | $0.35 | $-1.81 | ||
| Q2 25 | $0.17 | $-1.17 | ||
| Q1 25 | $-0.73 | $-1.57 | ||
| Q4 24 | $-0.79 | $-1.34 | ||
| Q3 24 | $0.01 | $-1.40 | ||
| Q2 24 | $0.54 | $-1.52 | ||
| Q1 24 | $-1.15 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $167.6M | $-80.0M |
| 总资产 | $450.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $79.0M | $421.0M | ||
| Q3 25 | $90.8M | $202.5M | ||
| Q2 25 | $80.0M | $176.3M | ||
| Q1 25 | $77.7M | $127.1M | ||
| Q4 24 | $86.2M | $174.0M | ||
| Q3 24 | $104.7M | $150.6M | ||
| Q2 24 | $105.4M | $480.7M | ||
| Q1 24 | $103.0M | $112.3M |
| Q4 25 | $167.6M | $-80.0M | ||
| Q3 25 | $172.2M | $9.2M | ||
| Q2 25 | $164.9M | $151.3M | ||
| Q1 25 | $162.3M | $144.2M | ||
| Q4 24 | $177.1M | $255.0M | ||
| Q3 24 | $195.1M | $346.8M | ||
| Q2 24 | $196.9M | $432.4M | ||
| Q1 24 | $192.3M | $140.3M |
| Q4 25 | $450.2M | $1.5B | ||
| Q3 25 | $436.9M | $1.2B | ||
| Q2 25 | $440.8M | $1.3B | ||
| Q1 25 | $452.4M | $1.3B | ||
| Q4 24 | $424.4M | $1.5B | ||
| Q3 24 | $455.6M | $1.5B | ||
| Q2 24 | $477.1M | $1.6B | ||
| Q1 24 | $486.8M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-12.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | -8.3% | -48.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-12.4M | $-99.8M | ||
| Q3 25 | $11.8M | $-91.4M | ||
| Q2 25 | $3.9M | $-108.3M | ||
| Q1 25 | $-6.5M | $-166.5M | ||
| Q4 24 | $-22.1M | $-79.3M | ||
| Q3 24 | $3.1M | $-67.0M | ||
| Q2 24 | $5.7M | $-77.0M | ||
| Q1 24 | $-11.2M | $-190.7M |
| Q4 25 | $-12.9M | $-100.8M | ||
| Q3 25 | $10.4M | $-92.7M | ||
| Q2 25 | $2.8M | $-110.7M | ||
| Q1 25 | $-7.8M | $-167.8M | ||
| Q4 24 | $-23.8M | $-79.5M | ||
| Q3 24 | $1.6M | $-68.6M | ||
| Q2 24 | $2.4M | $-79.0M | ||
| Q1 24 | $-13.5M | $-193.9M |
| Q4 25 | -8.3% | -48.6% | ||
| Q3 25 | 5.9% | -58.0% | ||
| Q2 25 | 1.7% | -66.5% | ||
| Q1 25 | -5.0% | -120.5% | ||
| Q4 24 | -16.3% | -48.3% | ||
| Q3 24 | 0.9% | -49.2% | ||
| Q2 24 | 1.4% | -53.7% | ||
| Q1 24 | -7.7% | -178.2% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.8% | 0.8% | ||
| Q2 25 | 0.6% | 1.5% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 1.2% | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 1.8% | 1.4% | ||
| Q1 24 | 1.3% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.95× | — | ||
| Q2 24 | 0.52× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CATO
| Retail Segment | $154.7M | 100% |
| Credit Card | $5.3M | 3% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
